Nkgen Biotech, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OTC.Pink
NKGen Biotech has filed an amendment to its S-1 registration statement, outlining plans for the potential issuance of common stock upon exercise of warrants and conversion of notes, as well as the resale of common stock by existing securityholders.
OTC.Pink
S-1/A: NKGen Biotech Eyes $148.4 Million Through Warrant Exercises, Files Amendment No. 3 to Form S-1
NKGen Biotech aims to raise capital through the potential exercise of outstanding warrants while registering the resale of a significant number of common shares by existing securityholders.